Bio-Edge Sugar Balance Liquid (Australia Biotechnology Research Pty Ltd)
Product Name
Bio-Edge Sugar Balance Liquid
Date of review outcome
Date of publication
Mar-2023
Outcome
Medicine continues to be permitted for supply
Is it safe to continue using this medicine?
Yes, based on the sponsor's certification. However, follow the recommended actions below.
What action should consumers take?
Seek advice from a suitably qualified health professional if you have been taking this medicine to prevent, treat or manage diabetes. Consider whether this medicine is right for you based on it potentially not working as expected in relation to these uses and maintaining energy, enhancing the role of insulin, aiding the digestion and metabolism of fats and proteins, inhibiting sugar absorption, and reducing sweet taste recognition.
Review scope
Targeted
Information reviewed
ARTG Record, Website
Issues related to safety
The website for this medicine contained claims about diabetes and blood sugar control. These claims are not permitted for listed medicines without prior evaluation or approval from the TGA. References to non-permitted claims have the potential to lead consumers to delay access to timely advice or treatment from a suitability qualified health professional when required, which may result in adverse outcomes. While advertising of this nature is unacceptable, these claims have been removed and this medicine was never supplied in Australia. Therefore, this medicine is unlikely to pose an immediate risk to consumer health and safety.
Issues related to efficacy
The website for this medicine contained claims specified in 'What action should consumers take?' above. However, these claims were not covered by the sponsor's certification that they held evidence to substantiate them.
Actions taken during the review
The sponsor updated the website for this medicine to remove references to diabetes, blood sugar control, and other claims that were not included in the ARTG Record. Nevertheless, the TGA issued an educational letter to the sponsor outlining the issues with this medicine.